ImmunityBio, Inc (IBRX) insider trading

Every open-market stock purchase and sale by ImmunityBio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Christobel Selecky (Director) and 1 other sold $2.7M in the last 90 days.
  • Last insider buy: Patrick Soon-Shiong (Insider), n/a, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $8.4M (10 sales). Last close $8.80 on Jul 8, 2026.

Recent IBRX insider trades

DateInsiderTradeValue
Jul 2, 2026Cheryl Cohen (Director)Sold$1.2M
Jul 2, 2026Cheryl Cohen (Director)Bought (not open market)—
Jul 1, 2026Christobel Selecky (Director)Sold$1.4M
Jul 1, 2026Christobel Selecky (Director)Bought (not open market)—
Jul 1, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 30, 2026Christobel Selecky (Director)Sold$9K
Jun 30, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 30, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 29, 2026Christobel Selecky (Director)Sold$862K
Jun 29, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 29, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 29, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 24, 2026Barry J. Simon (Director)Sold$197K
Jun 9, 2026Cheryl Cohen (Director)Bought (not open market)—
Jun 9, 2026Christobel Selecky (Director)Bought (not open market)—
Jun 9, 2026Bruce Wendel (Director)Bought (not open market)—
Jun 9, 2026Wesley Clark (Director)Bought (not open market)—
Jun 9, 2026Michael D Blaszyk (Director)Bought (not open market)—
Jun 9, 2026Linda Maxwell (Director)Bought (not open market)—
Jun 4, 2026Barry J. Simon (Director)Sold$165K
Mar 31, 2026Patrick Soon-Shiong (Officer)Bought (not open market)$25M
Mar 31, 2026Patrick Soon-Shiong (Officer)Bought (not open market)—
Feb 24, 2026Barry J. Simon (Director)Sold$901K
Feb 23, 2026Barry J. Simon (Director)Sold$1.7M
Feb 23, 2026Christobel Selecky (Director)Sold$250K

Who's trading IBRX

Get free alerts when an insider at ImmunityBio, Inc files a new trade →